{"id":53993,"date":"2023-02-16T13:03:29","date_gmt":"2023-02-16T12:03:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/"},"modified":"2023-02-16T13:03:29","modified_gmt":"2023-02-16T12:03:29","slug":"basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/","title":{"rendered":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by about five times<\/i>\n<\/p>\n<p>PRINCETON, N.J. &amp; NEW YORK&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24BMY&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$BMY<\/a>&#8211;Kareem Abdul-Jabbar is teaming up with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AFib) and its symptoms as part of the <i>No Time to Wait <\/i>campaign. In support of the campaign, Abdul-Jabbar will share his experience with AFib, including what led to his diagnosis, and encourage others to speak to a healthcare professional if they are having symptoms. Most common symptoms of AFib include irregular heartbeat, heart racing, chest pain, shortness of breath, fatigue and light-headedness.<sup>1<\/sup>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/19\/KAJ_Longform_Conform_0117-830_Ver_2.mp4\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711309\/5\/BMS_Pfizer_New.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711309\/21\/BMS_Pfizer_New.jpg\"><\/a><\/p>\n<p>\n\u201cWhen I first started to experience symptoms like shortness of breath and light-headedness, I dismissed them until they reached a point where I could no longer ignore them and I ended up in the hospital where I was diagnosed with AFib,\u201d Abdul-Jabbar said. \u201cI\u2019ve joined the <i>No Time to Wait <\/i>campaign with Bristol Myers Squibb and Pfizer because I want my experience to help others understand the symptoms of AFib. Health is nothing to play around with. I hope my story can help motivate others to speak with a healthcare professional if they are experiencing symptoms.\u201d\n<\/p>\n<p>\nApproximately 9.5 million people in the U.S. are projected to have AFib in 2023; however, many people remain undiagnosed, dismissing their symptoms because they can come and go and can vary.<sup>1,2<\/sup> Because AFib increases the risk of stroke by about five times, it is important for individuals to seek medical attention if they are experiencing these symptoms.<sup>3<\/sup> Only a healthcare professional can determine whether symptoms indicate AFib or another condition.\n<\/p>\n<p>\n\u201cIn my experience, I have seen many patients ignore or dismiss their symptoms, potentially delaying diagnosis and treatment,\u201d said Andrea Russo, M.D., cardiologist and academic chief in the division of cardiology and director of cardiac electrophysiology and arrhythmia services at Cooper University Health System in Camden, N.J. \u201cBecause AFib can lead to serious consequences, including increasing the risk of stroke, it\u2019s critical individuals are empowered to speak with a healthcare professional about any symptoms they may have. No symptom or concern is too small or insignificant.\u201d\n<\/p>\n<p>\n\u201cBristol Myers Squibb and Pfizer are committed to supporting patient communities and our partnership with Kareem, alongside both professional and patient advocacy organizations, on <i>No Time to Wait <\/i>is one way we are acting on this long-term commitment,\u201d said Tom Garner, Head of U.S. Cardiovascular and Established Brands, Bristol Myers Squibb. \u201cBy educating on the common symptoms of AFib, we believe we can help people better understand the disease and encourage important and timely conversations with a healthcare professional.\u201d\n<\/p>\n<p>\nPeople can visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.notimetowait.com%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=www.NoTimetoWait.com&amp;index=1&amp;md5=a4e73e37beb9bb79b9a3a17a16094d51\" rel=\"nofollow noopener\" shape=\"rect\">www.NoTimetoWait.com<\/a> to learn more about Abdul-Jabbar\u2019s diagnosis journey, as well as common AFib symptoms and how to prepare for a medical appointment.\n<\/p>\n<p>\n<b>About the <i>No Time to Wait<\/i> Campaign<\/b>\n<\/p>\n<p>\nThe Bristol Myers Squibb-Pfizer Alliance launched the <i>No Time to Wait<\/i> campaign to raise awareness of symptoms of atrial fibrillation (AFib) and deep vein thrombosis (DVT)\/pulmonary embolism (PE) in 2020. Seeking medical attention early may help reduce the chance of AFib leading to, or DVT\/PE becoming, something more serious. AFib, the most common irregular heartbeat, increases the risk for stroke by approximately five times. DVT is a condition where the blood forms clots, which could travel to your lungs and lead to a PE \u2013 and can be deadly. To learn more about AFib and DVT\/PE, including the associated symptoms and how to prepare for a healthcare appointment, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.notimetowait.com%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=www.NoTimetoWait.com.&amp;index=2&amp;md5=2b83d82ef557ea7bd793159339552836\" rel=\"nofollow noopener\" shape=\"rect\">www.NoTimetoWait.com.<\/a>\n<\/p>\n<p>\n<b>About the Bristol Myers Squibb-Pfizer Collaboration<\/b>\n<\/p>\n<p>\nThe Bristol Myers Squibb-Pfizer Alliance (the Alliance) is committed to driving education and awareness about atrial fibrillation and deep vein thrombosis (DVT) and\/or pulmonary embolism (PE). With long-standing cardiovascular leadership, global scale and expertise in this field, the Alliance strives to implement global, research-driven approaches to illuminate and address the unmet needs around strokes related to non-valvular atrial fibrillation, which are often fatal or debilitating. Through collaborations with non-profit organizations, the Alliance aims to provide patients, healthcare professionals and decision makers with the information they need to understand and take appropriate action on risk factors associated with stroke and other cardiovascular conditions.\n<\/p>\n<p>\n<b>About Bristol Myers Squibb<\/b>\n<\/p>\n<p>\nBristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=BMS.com&amp;index=3&amp;md5=a9c07346a178779ce10846d669296f1d\" rel=\"nofollow noopener\" shape=\"rect\">BMS.com<\/a> or follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbristol-myers-squibb&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=25b9419fcbec27c902011b90f88a1f52\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Ftwitter.com%2Fbmsnews&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=2f0d74c6a5ad8605fc2a2a825756bf39\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fbristolmyerssquibb&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=YouTube&amp;index=6&amp;md5=47acc53176d8c08a2f09dd102b8b24c8\" rel=\"nofollow noopener\" shape=\"rect\">YouTube<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBristolMyersSquibb%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=ca34dfda79017454703c89b98981a157\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbristolmyerssquibb&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=Instagram&amp;index=8&amp;md5=a2f4eb2898360c29a1b7b1fb072bad15\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a>.\n<\/p>\n<p>\n<b>About Pfizer Inc.: Breakthroughs That Change Patients\u2019 Lives<\/b>\n<\/p>\n<p>\nAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world&#8217;s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Pfizer.com%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=www.Pfizer.com&amp;index=9&amp;md5=8618e4ee7229e3b18535c363e2c630f5\" rel=\"nofollow noopener\" shape=\"rect\">www.Pfizer.com<\/a>. In addition, to learn more, please visit us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Pfizer.com%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=www.Pfizer.com&amp;index=10&amp;md5=49fcecd6aa76be5f4a295c63e43f5cc4\" rel=\"nofollow noopener\" shape=\"rect\">www.Pfizer.com<\/a> and follow us on Twitter at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fpfizer&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=%40Pfizer&amp;index=11&amp;md5=e0e22e561c0d1d1dcc18984b6a0c2bd9\" rel=\"nofollow noopener\" shape=\"rect\">@Pfizer<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fpfizer_news&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=%40Pfizer+News&amp;index=12&amp;md5=ef9884bd36b88b2b8a4266d9f724b48a\" rel=\"nofollow noopener\" shape=\"rect\">@Pfizer News<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpfizer%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=13&amp;md5=9fa808b678ffa83278b8337479b82064\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fpfizer&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=YouTube&amp;index=14&amp;md5=fa0e6843df8719a01d5bc2aaaa76e08d\" rel=\"nofollow noopener\" shape=\"rect\">YouTube<\/a> and like us on Facebook at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FPfizer%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=Facebook.com%2FPfizer&amp;index=15&amp;md5=4ecd9054742d2d0dd43c1c40381ae208\" rel=\"nofollow noopener\" shape=\"rect\">Facebook.com\/Pfizer<\/a>.\n<\/p>\n<p>\ncorporatefinancial-news\n<\/p>\n<p>\n_________________<br \/>\n<br \/><sup>1<\/sup> Centers for Disease Control and Prevention. (2022, October 14). Atrial fibrillation. Centers for Disease Control and Prevention. Retrieved November 3, 2022, from <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cdc.gov%2Fheartdisease%2Fatrial_fibrillation.htm&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.cdc.gov%2Fheartdisease%2Fatrial_fibrillation.htm&amp;index=16&amp;md5=7b63e1e68ce7c3953a263be2424f0c9e\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.cdc.gov\/heartdisease\/atrial_fibrillation.htm<\/a><br \/><sup>2<\/sup> Collila 2023 AFib Projection<br \/>\n<br \/><sup>3<\/sup> High blood pressure, afib and your risk of stroke. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.heart.org%2F&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=www.heart.org.&amp;index=17&amp;md5=c9ba7d0208ecd7a439e1ef19286041ee\" rel=\"nofollow noopener\" shape=\"rect\">www.heart.org.<\/a> (2022, September 14). Retrieved October 20, 2022, from <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.heart.org%2Fen%2Fhealth-topics%2Fatrial-fibrillation%2Fwhy-atrial-fibrillation-af-or-afib&amp;esheet=53316577&amp;newsitemid=20230210005387&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.heart.org%2Fen%2Fhealth-topics%2Fatrial-fibrillation%2Fwhy-atrial-fibrillation-af-or-afib-+matters%2Fhigh-blood-pressure-afib-and-your-risk-of-stroke&amp;index=18&amp;md5=ed454ced0e1b96c2c2440f6eb88f5e22\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.heart.org\/en\/health-topics\/atrial-fibrillation\/why-atrial-fibrillation-af-or-afib- matters\/high-blood-pressure-afib-and-your-risk-of-stroke<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Inquiries:<br \/>\n<br \/><\/b>Bristol Myers Squibb<br \/>\n<br \/>Media: <a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;m&#x65;d&#x69;a&#x40;&#98;&#x6d;&#115;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;e&#x64;&#105;&#x61;&#64;b&#x6d;s&#x2e;&#99;&#x6f;&#109;<\/a><br \/>Investors: Timothy Power +1 (609) 252-7509, <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;to&#x3a;&#x74;&#x69;&#109;ot&#x68;&#x79;&#x2e;&#112;&#111;w&#x65;&#x72;&#x40;&#98;&#109;s&#x2e;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x74;&#x69;&#x6d;&#x6f;&#x74;&#x68;&#x79;&#x2e;&#x70;&#x6f;&#x77;&#x65;&#x72;&#x40;&#x62;&#x6d;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nPfizer Inc.<br \/>\n<br \/>Media: <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x50;&#x66;&#x69;&#x7a;&#x65;&#x72;&#x4d;&#101;&#100;&#105;&#97;&#82;&#101;&#108;&#97;&#116;&#105;&#111;ns&#64;Pfize&#x72;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">P&#102;&#105;&#x7a;&#x65;r&#77;&#101;&#x64;&#x69;&#x61;R&#101;&#108;&#x61;&#x74;io&#110;&#x73;&#x40;&#x50;f&#105;&#122;&#x65;&#x72;&#46;c&#111;&#x6d;<\/a> +1 (212) 733-1226<br \/>\n<br \/>Investors: <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#111;&#x3a;&#73;&#x52;&#64;&#x50;f&#105;&#x7a;&#101;&#x72;&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x49;&#x52;&#64;P&#x66;&#x69;&#122;er&#x2e;&#x63;&#111;m<\/a> +1 (212) 733-4848\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by about five times PRINCETON, N.J. &amp; NEW YORK&#8211;(BUSINESS WIRE)&#8211;$BMY&#8211;Kareem Abdul-Jabbar is teaming up with Bristol &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53993","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by about five times PRINCETON, N.J. &amp; NEW YORK&#8211;(BUSINESS WIRE)&#8211;$BMY&#8211;Kareem Abdul-Jabbar is teaming up with Bristol ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T12:03:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms\",\"datePublished\":\"2023-02-16T12:03:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/\"},\"wordCount\":1063,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230210005387\\\/en\\\/1711313\\\/21\\\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/\",\"name\":\"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230210005387\\\/en\\\/1711313\\\/21\\\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\",\"datePublished\":\"2023-02-16T12:03:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230210005387\\\/en\\\/1711313\\\/21\\\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230210005387\\\/en\\\/1711313\\\/21\\\/KAJ_Longform_Conform_0117-830_Ver_2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/","og_locale":"en_US","og_type":"article","og_title":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend","og_description":"Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by about five times PRINCETON, N.J. &amp; NEW YORK&#8211;(BUSINESS WIRE)&#8211;$BMY&#8211;Kareem Abdul-Jabbar is teaming up with Bristol ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-16T12:03:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms","datePublished":"2023-02-16T12:03:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/"},"wordCount":1063,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/","url":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/","name":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg","datePublished":"2023-02-16T12:03:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230210005387\/en\/1711313\/21\/KAJ_Longform_Conform_0117-830_Ver_2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/basketball-legend-kareem-abdul-jabbar-joins-no-time-to-wait-campaign-to-raise-awareness-of-atrial-fibrillation-afib-and-its-symptoms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53993"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53993\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}